B-Lymphocytes

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
Christina Bergmann, Fabian Müller, Jörg H W Distler, Andrea-Hermina Györfi, Simon Völkl, Michael Aigner, Sascha Kretschmann, Hannah Reimann, Thomas Harrer, Nadine Bayerl, Sebastian Boeltz, Andreas Wirsching, Jule Taubmann, Wolf Rösler, Bernd Spriewald, Jochen Wacker, Armin Atzinger, Michael Uder, Torsten Kuwert, Andreas Mackensen, Georg Schett

Annals of the Rheumatic Diseases Aug 2023, 82 (8) 1117-1120; DOI: 10.1136/ard-2023-223952
Irreversible covalent Bruton’s tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial
Tsutomu Takeuchi, Sakae Tanaka, Mitsuru Murata, Yoshiya Tanaka

Annals of the Rheumatic Diseases Aug 2023, 82 (8) 1025-1034; DOI: 10.1136/ard-2022-223759
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Rona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz-Singer, Lorraine Harper, Toshiko Ito-Ihara, Nader Khalidi, Rainer Klocke, Curry Koening, Yoshinori Komagata, Carol Langford, Peter Lanyon, Raashid Luqmani, Carol McAlear, Larry W Moreland, Kim Mynard, Patrick Nachman, Christian Pagnoux, Chen Au Peh, Charles Pusey, Dwarakanathan Ranganathan, Rennie L Rhee, Robert Spiera, Antoine G Sreih, Vladamir Tesar, Giles Walters, Caroline Wroe, David Jayne, Peter A Merkel

Annals of the Rheumatic Diseases Jul 2023, 82 (7) 937-944; DOI: 10.1136/ard-2022-223559
Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al
Rona M Smith, Peter A Merkel, David Jayne

Annals of the Rheumatic Diseases Jan 2023, 82 (1) e24; DOI: 10.1136/annrheumdis-2020-219329
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al
Philippe Guilpain, Clément Le Bihan, Vincent Foulongne, Patrice Taourel, Nathalie Pansu, Alexandre Thibault Jacques Maria, Boris Jung, Romaric Larcher, Kada Klouche, Vincent Le Moing

Annals of the Rheumatic Diseases Mar 2021, 80 (3) e38; DOI: 10.1136/annrheumdis-2020-217955
Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
Silvia Suárez-Díaz, Claudia Morán-Castaño, Rubén Coto-Hernández, Lourdes Mozo-Avellaneda, Carlos Suárez-Cuervo, Luis Caminal-Montero

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e99; DOI: 10.1136/annrheumdis-2020-218246
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?
Ioannis Parodis, Frederic A Houssiau

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 15-19; DOI: 10.1136/annrheumdis-2021-221270
B cell depletion impairs vaccination-induced CD8⁺ T cell responses in a type I interferon-dependent manner
Theresa Graalmann, Katharina Borst, Himanshu Manchanda, Lea Vaas, Matthias Bruhn, Lukas Graalmann, Mario Koster, Murielle Verboom, Michael Hallensleben, Carlos Alberto Guzmán, Gerd Sutter, Reinhold E Schmidt, Torsten Witte, Ulrich Kalinke

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1537-1544; DOI: 10.1136/annrheumdis-2021-220435
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
Maria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah, Aran Singanayagam, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe, Stephen P McAdoo

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1322-1329; DOI: 10.1136/annrheumdis-2021-220626
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
Michael Markus Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1355-1356; DOI: 10.1136/annrheumdis-2021-220408

Main menu

B-Lymphocytes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

B-Lymphocytes

Pages